Price
No data yet.
Social Signal Score
Revenue
$2.21M-65.07%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Michael Kazley
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 4
- Beta
- 0.09
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 835.15
Financials
Revenue
$2.21M-65.1%Net Income
$-41.07M-5279.1%EBITDA
$-3.21M-841.6%Free Cash Flow
$-5.96MEPS (diluted)
$-1.32-100.4%Shares Outstanding (diluted)
31.05M+1187204.0%Operating Expenses
$5.42MCash & Debt
$6.97MReturn of Capital
$0.00Dividend per Share
$4.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-641.98M | $-110.31 |
| 2024 | $0.00 | $-7.22M | $-12.68 |
| 2023 | $10.46M | $-6.14M | $-550.08 |
| 2022 | $14.40M | $-10.61M | $-1767.93 |
| 2021 | $10.20M | $-5.82M | $-920.46 |
| 2020 | $9.93M | $-11.04M | $-1927.66 |
| 2019 | $6.60M | $-9.66M | $-2968.11 |
| 2018 | $12.51M | $-6.54M | $-2369.15 |
| 2017 | $18.23M | $-7.40M | $-2940.00 |
| 2016 | $11.90M | $-13.15M | $-8575.00 |
| 2015 | $4.38M | $-18.97M | $-41772.00 |
| 2014 | $1.05M | $-15.19M | $-47468.00 |
| 2013 | $3.48M | $-16.04M | $-64312.00 |
| 2012 | $6.95M | $-7.03M | $-36750.00 |
Valuation
SDEVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
113Social Signal Score
Mentions (1)
- Newsbenzinga.com·6d ago·Positive
Stablecoin Development Stock Skyrockets Tuesday: What's Happening? Shares of Stablecoin Development Corporation (NYSE:SDEV) are surging on heavy trading volume Tuesday afternoon, despite no company-specific news for the session. Here's a closer look at what could be driving the sudden rally.
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $-0.60 per share
Typical surprise -57.1% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$0.01 vs $-0.55beat
- Fri, May 15$0.10 vs $-1.00beat
- Fri, Nov 7$-1.15 vs $-1.05miss
- Thu, Aug 14$-1.65 vs $-1.05miss
- Thu, May 15$-3.33 vs $-1.20miss
- Wed, Apr 2$-23.45 vs $-1.20miss
Estimates and results for SDEV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SDEV officers and directors.
- Bought
- $8.2m
- Sold
- $81k
6 trades
3 trades
- Kazley Michael Johnsolddirector, 10 percent owner, officer: Chief Executive Officer·24,720 @ $1.09·$27k·Jun 15, 2026·filing
- Framework Ventures Iv L.p.sold
- R01 Fund Lpsold
- Framework Ventures Iv L.p.bought
- R01 Fund Lpbought
- Kazley Michael Johnboughtdirector, 10 percent owner, officer: Chief Executive Officer·53,679,974 @ $0.05·$2.7m·Jan 16, 2026·filing
- Kazley Michael Johnboughtdirector, 10 percent owner, officer: Chief Executive Officer·11,332,020 @ $0.01·$113k·Oct 16, 2025·filing
- Framework Ventures Iv L.p.bought
19 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SDEV.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.